Electrolyte Disturbances and Critical Care Seizures

Chapter
First Online:
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Electrolyte disorders are common in critically ill patients. The brain is only partially protected from these imbalances by the blood–brain barrier. Neuronal excitability and synaptic transmissions are affected by changes in extracellular ion concentration and osmolality. Hyponatremia is by far the most common cause of seizures due to an electrolyte imbalance. The risk depends on the severity and the rate of onset. Prompt recognition and careful treatment are required to avoid irreversible complications. Seizures can also occur in the setting of hypernatremia but are most often due either to an extra-pontine demyelination syndrome or an excessively rapid correction of sodium levels. Hypocalcemia can also cause seizures, mainly in neonates. Hypercalcemia and hypomagnesemia are also associated with acute seizures, although a direct causal relationship is less likely and associated complications, especially a posterior reversible encephalopathy syndrome, should be actively sought as an alternative etiology. Acid-base disorders are common in the critically ill but they do not appear to be a major cause of acute seizures. Acute acidosis can be the consequence of seizures or suggests an acute intoxication as the etiology. On the other hand, acute inhalation of 5% CO2 is a potent anti-seizure agent.

Keywords

Electrolytes Acid-base disorders Sodium Calcium Magnesium Seizures Status epilepticus 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Barron R, Freebairn R. Electrolyte disorders in the critically ill. Anaesth Intensive Care Med. 2010;11:523–8. doi: 10.1016/j.mpaic.2010.09.010.CrossRefGoogle Scholar
  2. 2.
    Annegers JF, Hauser WA, Lee JR, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935–1984. Epilepsia. 1995;36:327–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Fields MC, Labovitz DL, French JA. Hospital-onset seizures: an inpatient study. JAMA Neurol. 2013;70:360–4. doi: 10.1001/2013.jamaneurol.337.PubMedCrossRefGoogle Scholar
  5. 5.
    Narayanan JT, Murthy JMK. New-onset acute symptomatic seizure in a neurological intensive care unit. Neurol India. 2007;55:136–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Sandler DL, Burchfield DJ, Riley WJ, Drummond WH. A comparison of CSF and serum magnesium levels in new born NICU infants. Seattle: Society for Pediatric Research; 1995.Google Scholar
  7. 7.
    Pasantes-Morales H, Tuz K. Volume changes in neurons: hyperexcitability and neuronal death. Contrib Nephrol. 2006;152:221–40. doi: 10.1159/000096326.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosen AS, Andrew RD. Osmotic effects upon excitability in rat neocortical slices. Neuroscience. 1990;38:579–90.PubMedCrossRefGoogle Scholar
  9. 9.
    Somjen GG. Ions in the brain: normal function, seizures, and stroke. New York: OUP; 2004.Google Scholar
  10. 10.
    Schwartzkroin PA, Baraban SC, Hochman DW. Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res. 1998;32:275–85.PubMedCrossRefGoogle Scholar
  11. 11.
    Somjen GG. Low external NaCl concentration and low osmolarity enhance voltage-gated Ca currents but depress K currents in freshly isolated rat hippocampal neurons. Brain Res. 1999;851:189–97.PubMedCrossRefGoogle Scholar
  12. 12.
    Chebabo SR, Hester MA, Aitken PG, Somjen GG. Hypotonic exposure enhances synaptic transmission and triggers spreading depression in rat hippocampal tissue slices. Brain Res. 1995;695:203–16.PubMedCrossRefGoogle Scholar
  13. 13.
    Andrew RD, Fagan M, Ballyk BA, Rosen AS. Seizure susceptibility and the osmotic state. Brain Res. 1989;498:175–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61:657–68. doi: 10.1007/s00018-003-3319-x.PubMedCrossRefGoogle Scholar
  15. 15.
    Hyzinski-García MC, Vincent MY, Haskew-Layton RE, et al. Hypo-osmotic swelling modifies glutamate-glutamine cycle in the cerebral cortex and in astrocyte cultures. J Neurochem. 2011;118:140–52. doi: 10.1111/j.1471-4159.2011.07289.x.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Avoli M, Drapeau C, Perreault P, et al. Epileptiform activity induced by low chloride medium in the CA1 subfield of the hippocampal slice. J Neurophysiol. 1990;64:1747–57.PubMedGoogle Scholar
  17. 17.
    Huang R, Somjen GG. Effects of hypertonia on voltage-gated ion currents in freshly isolated hippocampal neurons, and on synaptic currents in neurons in hippocampal slices. Brain Res. 1997;748:157–67.PubMedCrossRefGoogle Scholar
  18. 18.
    Hille B, Woodhull AM, Shapiro BI. Negative surface charge near sodium channels of nerve: divalent ions, monovalent ions, and pH. Philos Trans R Soc Lond Ser B Biol Sci. 1975;270:301–18.CrossRefGoogle Scholar
  19. 19.
    Han P, Trinidad BJ, Shi J. Hypocalcemia-induced seizure: demystifying the calcium paradox. ASN Neuro. 2015; doi: 10.1177/1759091415578050.Google Scholar
  20. 20.
    Agopyan N, Avoli M. Synaptic and non-synaptic mechanisms underlying low calcium bursts in the in vitro hippocampal slice. Exp Brain Res. 1988;73:533–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Han P, Trinidad BJ, Shi J. Hypocalcemia-induced seizure: demystifying the calcium paradox. ASN Neuro. 2015;7 doi: 10.1177/1759091415578050.
  22. 22.
    Roper SN, Obenaus A, Dudek FE. Increased propensity for nonsynaptic epileptiform activity in immature rat hippocampus and dentate gyrus. J Neurophysiol. 1993;70:857–62.PubMedGoogle Scholar
  23. 23.
    Isaev D, Ivanchick G, Khmyz V, et al. Surface charge impact in low-magnesium model of seizure in rat hippocampus. J Neurophysiol. 2012;107:417–23. doi: 10.1152/jn.00574.2011.PubMedCrossRefGoogle Scholar
  24. 24.
    Tancredi V, Avoli M, Hwa GG. Low-magnesium epilepsy in rat hippocampal slices: inhibitory postsynaptic potentials in the CA1 subfield. Neurosci Lett. 1988;89:293–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Anderson WW, Lewis DV, Swartzwelder HS, Wilson WA. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 1986;398:215–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Hallak M. Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain. Magnese Res Off Organ Int Soc Dev Res Magnes. 1998;11:117–31.Google Scholar
  27. 27.
    Del Castillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. J Physiol. 1954;124:370–84.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Katz B. Nerve, muscle, and synapse. New York: McGraw-Hill; 1966.Google Scholar
  29. 29.
    Somjen GG. Ions in the brain: normal function, seizures, and stroke. New York: Oxford University Press; 2004.Google Scholar
  30. 30.
    Hille B. Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J. 1978;22:283–94. doi: 10.1016/S0006-3495(78)85489-7.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Zito K, Scheuss V, Knott G, et al. Rapid functional maturation of nascent dendritic spines. Neuron. 2009;61:247–58. doi: 10.1016/j.neuron.2008.10.054.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Feng Z, Durand DM. Suppression of excitatory synaptic transmission can facilitate low-calcium epileptiform activity in the hippocampus in vivo. Brain Res. 2004;1030:57–65. doi: 10.1016/j.brainres.2004.09.063.PubMedCrossRefGoogle Scholar
  33. 33.
    Ruusuvuori E, Kaila K. Carbonic anhydrases and brain pH in the control of neuronal excitability. Subcell Biochem. 2014;75:271–90. doi: 10.1007/978-94-007-7359-2_14.PubMedCrossRefGoogle Scholar
  34. 34.
    Hsu KS, Liang YC, Huang CC. Influence of an extracellular acidosis on excitatory synaptic transmission and long-term potentiation in the CA1 region of rat hippocampal slices. J Neurosci Res. 2000;62:403–15.PubMedCrossRefGoogle Scholar
  35. 35.
    Walz W, Harold DE. Brain lactic acidosis and synaptic function. Can J Physiol Pharmacol. 1990;68:164–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Velísek L. Extracellular acidosis and high levels of carbon dioxide suppress synaptic transmission and prevent the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Hippocampus. 1998;8:24–32. doi: 10.1002/(sici)1098-1063(1998)8:1<24::aid-hipo3>3.3.co;2-2.PubMedCrossRefGoogle Scholar
  37. 37.
    de Curtis M, Manfridi A, Biella G. Activity-dependent pH shifts and periodic recurrence of spontaneous interictal spikes in a model of focal epileptogenesis. J Neurosci. 1998;18:7543–51.PubMedGoogle Scholar
  38. 38.
    Pavlov I, Kaila K, Kullmann DM, Miles R. Cortical inhibition, pH and cell excitability in epilepsy: what are optimal targets for antiepileptic interventions? J Physiol. 2013;591:765–74. doi: 10.1113/jphysiol.2012.237958.PubMedCrossRefGoogle Scholar
  39. 39.
    Vandergheynst F, Sakr Y, Felleiter P, et al. Incidence and prognosis of dysnatraemia in critically ill patients: analysis of a large prevalence study. Eur J Clin Investig. 2013;43:933–48. doi: 10.1111/eci.12123.CrossRefGoogle Scholar
  40. 40.
    Funk G-C, Lindner G, Druml W, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36:304–11. doi: 10.1007/s00134-009-1692-0.PubMedCrossRefGoogle Scholar
  41. 41.
    Pollock AS, Arieff AI. Abnormalities of cell volume regulation and their functional consequences. Am J Phys. 1980;239:F195–205.Google Scholar
  42. 42.
    Tisdall M, Crocker M, Watkiss J, Smith M. Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J Neurosurg Anesthesiol. 2006;18:57–63.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Sakr Y, Rother S, Ferreira AMP, et al. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med. 2013;41:133–42. doi: 10.1097/CCM.0b013e318265f576.PubMedCrossRefGoogle Scholar
  44. 44.
    Laville M, Burst V, Peri A, Verbalis JG. Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases. Clin Kidney J. 2013;6:i1–i20. doi: 10.1093/ckj/sft113.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Sherlock M, O’Sullivan E, Agha A, et al. Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J. 2009;85:171–5. doi: 10.1136/pgmj.2008.072819.PubMedCrossRefGoogle Scholar
  46. 46.
    Kirkman MA, Albert AF, Ibrahim A, Doberenz D. Hyponatremia and brain injury: historical and contemporary perspectives. Neurocrit Care. 2013;18:406–16. doi: 10.1007/s12028-012-9805-y.PubMedCrossRefGoogle Scholar
  47. 47.
    Darmon M, Diconne E, Souweine B, et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care Lond Engl. 2013;17:R12. doi: 10.1186/cc11937.CrossRefGoogle Scholar
  48. 48.
    Stelfox HT, Ahmed SB, Khandwala F, et al. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care Lond Engl. 2008;12:R162. doi: 10.1186/cc7162.CrossRefGoogle Scholar
  49. 49.
    Kovesdy CP, Lott EH, Lu JL, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677–84. doi: 10.1161/CIRCULATIONAHA.111.065391.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Padhi R, Panda BN, Jagati S, Patra SC. Hyponatremia in critically ill patients. Indian J Crit Care Med. 2014;18:83–7. doi: 10.4103/0972-5229.126077.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Sodium disorders in critically ill neurologic patients: a focus on pharmacologic management. OA Critical Care. http://www.oapublishinglondon.com/article/1300. Accessed 20 Jul 2015Google Scholar
  52. 52.
    Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia. 2011;52:410–3. doi: 10.1111/j.1528-1167.2010.02939.x.PubMedGoogle Scholar
  53. 53.
    Ko S-H, Lim C-H, Kim J-Y, et al. Case of inappropriate ADH syndrome: hyponatremia due to polyethylene glycol bowel preparation. World J Gastroenterol WJG. 2014;20:12350–4. doi: 10.3748/wjg.v20.i34.12350.PubMedCrossRefGoogle Scholar
  54. 54.
    Richter S, Betz C, Geiger H. Severe hyponatremia with pulmonary and cerebral edema in an Ironman triathlete. Dtsch Med Wochenschr. 2007;132:1829–32. doi: 10.1055/s-2007-984973.PubMedCrossRefGoogle Scholar
  55. 55.
    Sue Y-M, Lee Y-L, Huang J-J. Acute hyponatremia, seizure, and rhabdomyolysis after ecstasy use. J Toxicol Clin Toxicol. 2002;40:931–2.PubMedCrossRefGoogle Scholar
  56. 56.
    Gill M, McCauley M. Psychogenic polydipsia: the result, or cause of, deteriorating psychotic symptoms? A case report of the consequences of water intoxication. Case Rep Psychiatry. 2015;2015:846459. doi: 10.1155/2015/846459.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Ganong CA, Kappy MS. Cerebral salt wasting in children. The need for recognition and treatment. Am J Dis Child. 1960;147:167–9.CrossRefGoogle Scholar
  58. 58.
    Çelik T, Tolunay O, Tolunay İ, Çelik Ü. Cerebral salt wasting in status epilepticus: two cases and review of the literature. Pediatr Neurol. 2014;50:397–9. doi: 10.1016/j.pediatrneurol.2013.11.019.PubMedCrossRefGoogle Scholar
  59. 59.
    Peri A, Pirozzi N, Parenti G, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Investig. 2010;33:671–82. doi: 10.1007/BF03346668.CrossRefGoogle Scholar
  60. 60.
    Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr. 2014;2:146. doi: 10.3389/fped.2014.00146.PubMedGoogle Scholar
  61. 61.
    Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain J Neurol. 2004;127:701–12. doi: 10.1093/brain/awh077.CrossRefGoogle Scholar
  62. 62.
    Cerdà-Esteve M, Cuadrado-Godia E, Chillaron JJ, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med. 2008;19:249–54. doi: 10.1016/j.ejim.2007.06.019.PubMedCrossRefGoogle Scholar
  63. 63.
    Betjes MGH. Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med. 2002;13:9–14.PubMedCrossRefGoogle Scholar
  64. 64.
    Diringer MN, Wu KC, Verbalis JG, Hanley DF. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol. 1992;31:543–50. doi: 10.1002/ana.410310513.PubMedCrossRefGoogle Scholar
  65. 65.
    Marupudi NI, Mittal S. Diagnosis and management of hyponatremia in patients with aneurysmal subarachnoid hemorrhage. J Clin Med. 2015;4:756–67. doi: 10.3390/jcm4040756.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990;27:106–8. doi: 10.1002/ana.410270118.PubMedCrossRefGoogle Scholar
  67. 67.
    Verbalis JG. Control of brain volume during hypoosmolality and hyperosmolality. Adv Exp Med Biol. 2006;576:113–29. discussion 361–363 doi: 10.1007/0-387-30172-0_8.PubMedCrossRefGoogle Scholar
  68. 68.
    Rabinstein AA, Wijdicks EFM. Hyponatremia in critically ill neurological patients. Neurologist. 2003;9:290–300. doi: 10.1097/01.nrl.0000095258.07720.89.PubMedCrossRefGoogle Scholar
  69. 69.
    Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int. 1989;35:69–75.PubMedCrossRefGoogle Scholar
  70. 70.
    Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994;35:181–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Azuma H, Akechi T, Furukawa TA. Absence status associated with focal activity and polydipsia-induced hyponatremia. Neuropsychiatr Dis Treat. 2008;4:495–8.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Primavera A, Fonti A, Giberti L, Cocito L. Recurrent absence status epilepticus and hyponatremia in a patient with polydipsia. Biol Psychiatry. 1995;38:189–91. doi: 10.1016/0006-3223(95)00145-7.PubMedCrossRefGoogle Scholar
  73. 73.
    Barolomei F, Gastaut JL. Complex partial status epilepticus provoked by hyponatremia. Eur Neurol. 1998;40:53–4.PubMedGoogle Scholar
  74. 74.
    Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991;19:758–62.PubMedCrossRefGoogle Scholar
  75. 75.
    Sharf RE. Seizure from hyponatremia in infants. Early recognition and treatment. Arch Fam Med. 1993;2:647–52.PubMedCrossRefGoogle Scholar
  76. 76.
    Bruce RC, Kliegman RM. Hyponatremic seizures secondary to oral water intoxication in infancy: association with commercial bottled drinking water. Pediatrics. 1997;100:E4.PubMedCrossRefGoogle Scholar
  77. 77.
    Farrar HC, Chande VT, Fitzpatrick DF, Shema SJ. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med. 1995;26:42–8. doi: 10.1016/S0196-0644(95)70236-9.PubMedCrossRefGoogle Scholar
  78. 78.
    Hanna S, Tibby SM, Durward A, Murdoch IA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr Oslo Nor. 2007;92:430–4.CrossRefGoogle Scholar
  79. 79.
    Hardesty DA, Kilbaugh TJ, Storm PB. Cerebral salt wasting syndrome in post-operative pediatric brain tumor patients. Neurocrit Care. 2012;17:382–7. doi: 10.1007/s12028-011-9618-4.PubMedCrossRefGoogle Scholar
  80. 80.
    Hoorn EJ, Halperin ML, Zietse R. Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM Mon J Assoc Physicians. 2005;98:529–40. doi: 10.1093/qjmed/hci081.CrossRefGoogle Scholar
  81. 81.
    Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med. 2014;40:320–31. doi: 10.1007/s00134-014-3210-2.PubMedCrossRefGoogle Scholar
  82. 82.
    Carlotti AP, Bohn D, Rutka JT, et al. A method to estimate urinary electrolyte excretion in patients at risk for developing cerebral salt wasting. J Neurosurg. 2001;95:420–4. doi: 10.3171/jns.2001.95.3.0420.PubMedCrossRefGoogle Scholar
  83. 83.
    Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol JASN. 1994;4:1522–30.PubMedGoogle Scholar
  84. 84.
    Sterns RH, Riggs JE, Schochet SS. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–42. doi: 10.1056/NEJM198606123142402.PubMedCrossRefGoogle Scholar
  85. 85.
    Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore). 1993;72:359–73.CrossRefGoogle Scholar
  86. 86.
    Sterns RH, Hix JK. Overcorrection of hyponatremia is a medical emergency. Kidney Int. 2009;76:587–9. doi: 10.1038/ki.2009.251.PubMedCrossRefGoogle Scholar
  87. 87.
    Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999;91:947–52. doi: 10.3171/jns.1999.91.6.0947.PubMedCrossRefGoogle Scholar
  88. 88.
    Decaux G. SIADH and vaptans. Ann Endocrinol. 2012;73:130–4. doi: 10.1016/j.ando.2012.04.005.CrossRefGoogle Scholar
  89. 89.
    Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med. 1996;124:197–203.PubMedCrossRefGoogle Scholar
  90. 90.
    Overgaard-Steensen C, Ring T. Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients. Crit Care Lond Engl. 2013;17:206. doi: 10.1186/cc11805.CrossRefGoogle Scholar
  91. 91.
    Lindner G, Funk G-C. Hypernatremia in critically ill patients. J Crit Care. 2013;28:216.e11–20. doi: 10.1016/j.jcrc.2012.05.001.Google Scholar
  92. 92.
    Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999;27:1105–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Waite MD, Fuhrman SA, Badawi O, et al. Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care. 2013;28:405–12. doi: 10.1016/j.jcrc.2012.11.013.PubMedCrossRefGoogle Scholar
  94. 94.
    Kumar S, Berl T. Sodium. Lancet Lond Engl. 1998;352:220–8. doi: 10.1016/S0140-6736(97)12169-9.CrossRefGoogle Scholar
  95. 95.
    Hoorn EJ, Betjes MGH, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant. 2008;23:1562–8. doi: 10.1093/ndt/gfm831.PubMedCrossRefGoogle Scholar
  96. 96.
    Odier C, Nguyen DK, Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol. 2010;257:1176–80. doi: 10.1007/s00415-010-5486-7.PubMedCrossRefGoogle Scholar
  97. 97.
    Brown WD, Caruso JM. Extrapontine myelinolysis with involvement of the hippocampus in three children with severe hypernatremia. J Child Neurol. 1999;14:428–33.PubMedCrossRefGoogle Scholar
  98. 98.
    Hbibi M, Abourazzak S, Babakhouya A, et al. Severe hypernatremic dehydration associated with cerebral venous and aortic thrombosis in the neonatal period. BMJ Case Rep. 2012; doi: 10.1136/bcr.07.2011.4426.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Fleischer LM, Wilson TA, Parker MM. Hypernatremic dehydration, diabetes insipidus, and cerebral venous sinus thrombosis in a neonate: a case report. J Med Case Rep. 2007;1:66. doi: 10.1186/1752-1947-1-66.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Castilla-Guerra L, del Carmen Fernández-Moreno M, López-Chozas JM, Fernández-Bolaños R. Electrolytes disturbances and seizures. Epilepsia. 2006;47:1990–8. doi: 10.1111/j.1528-1167.2006.00861.x.PubMedCrossRefGoogle Scholar
  101. 101.
    Andreoli TE, Reeves WB, Bichet DG. Endocrine control of water balance. Compr Physiol. 2010; doi: 10.1002/cphy.cp070314.Google Scholar
  102. 102.
    Welt LG, Orloff J, Kydd DM, Oltman JE. An example of cellular hyperosmolarity. J Clin Invest. 1950;29:935–9. doi: 10.1172/JCI102328.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Gupta MM. Calcium imbalance in hypoparathyroidism. J Assoc Physicians India. 1991;39:616–8.PubMedGoogle Scholar
  104. 104.
    Bhadada SK, Bhansali A, Upreti V, et al. Spectrum of neurological manifestations of idiopathic hypoparathyroidism and pseudohypoparathyroidism. Neurol India. 2011;59:586–9. doi: 10.4103/0028-3886.84342.PubMedCrossRefGoogle Scholar
  105. 105.
    Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J Intensive Care Med. 2013;28:166–77. doi: 10.1177/0885066611411543.PubMedCrossRefGoogle Scholar
  106. 106.
    Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis Off J Natl Kidney Found. 2001;37:689–98.CrossRefGoogle Scholar
  107. 107.
    Steele T, Kolamunnage-Dona R, Downey C, et al. Assessment and clinical course of hypocalcemia in critical illness. Crit Care Lond Engl. 2013;17:R106. doi: 10.1186/cc12756.CrossRefGoogle Scholar
  108. 108.
    Zhang Z, Xu X, Ni H, Deng H. Predictive value of ionized calcium in critically ill patients: an analysis of a large clinical database MIMIC II. PLoS One. 2014;9:e95204. doi: 10.1371/journal.pone.0095204.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Hästbacka J, Pettilä V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand. 2003;47:1264–9.PubMedCrossRefGoogle Scholar
  110. 110.
    Chernow B, Zaloga G, McFadden E, et al. Hypocalcemia in critically ill patients. Crit Care Med. 1982;10:848–51.PubMedCrossRefGoogle Scholar
  111. 111.
    Carlstedt F, Lind L, Rastad J, et al. Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Investig. 1998;28:898–903.CrossRefGoogle Scholar
  112. 112.
    Milman S, Epstein E. Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism. Endocr Pract. 2010;17:104–7. doi: 10.4158/EP10241.CR.CrossRefGoogle Scholar
  113. 113.
    Deroux A, Khouri C, Chabre O, et al. Severe acute neurological symptoms related to proton pump inhibitors induced hypomagnesemia responsible for profound hypoparathyroidism with hypocalcemia. Clin Res Hepatol Gastroenterol. 2014;38:e103–5. doi: 10.1016/j.clinre.2014.03.005.PubMedCrossRefGoogle Scholar
  114. 114.
    Maclsaac RJ, Seeman E, Jerums G. Seizures after alendronate. J R Soc Med. 2002;95:615–6.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Tsourdi E, Rachner TD, Gruber M, et al. Seizures associated with zoledronic acid for osteoporosis. J Clin Endocrinol Metab. 2011;96:1955–9. doi: 10.1210/jc.2011-0418.PubMedCrossRefGoogle Scholar
  116. 116.
    Cox RE. Hypoparathyroidism: an unusual cause of seizures. Ann Emerg Med. 1983;12:314–5.PubMedCrossRefGoogle Scholar
  117. 117.
    Mrowka M, Knake S, Klinge H, et al. Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery. Epileptic Disord Int Epilepsy J Videotape. 2004;6:85–7.Google Scholar
  118. 118.
    Fonseca OA, Calverley JR. Neurological manifestations of hypoparathyroidism. Arch Intern Med. 1967;120:202–6.PubMedCrossRefGoogle Scholar
  119. 119.
    Tsai P-L, Lian L-M, Chen W-H. Hypocalcemic seizure mistaken for idiopathic epilepsy in two cases of DiGeorge syndrome (chromosome 22q11 deletion syndrome). Acta Neurol Taiwanica. 2009;18:272–5.Google Scholar
  120. 120.
    Bindu M, Harinarayana CV. Hypoparathyroidism: a rare treatable cause of epilepsy–report of two cases. Eur J Neurol Off J Eur Fed Neurol Soc. 2006;13:786–8. doi: 10.1111/j.1468-1331.2006.01287.x.Google Scholar
  121. 121.
    Kinoshita H, Kokudo T, Ide T, et al. A patient with DiGeorge syndrome with spina bifida and sacral myelomeningocele, who developed both hypocalcemia-induced seizure and epilepsy. Seizure. 2010;19:303–5. doi: 10.1016/j.seizure.2010.04.005.PubMedCrossRefGoogle Scholar
  122. 122.
    Cheung ENM, George SR, Andrade DM, et al. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med Off J Am Coll Med Genet. 2014;16:40–4. doi: 10.1038/gim.2013.71.Google Scholar
  123. 123.
    Korkmaz HA, Dizdarer C, Ecevit CO. Hypocalcemic seizure in an adolescent with down syndrome: a manifestation of unrecognized celiac disease. Turk J Pediatr. 2013;55:536–8.PubMedGoogle Scholar
  124. 124.
    Erdeve O, Atasay B, Arsan S, et al. Hypocalcemic seizure due to congenital rickets in the first day of life. Turk J Pediatr. 2007;49:301–3.PubMedGoogle Scholar
  125. 125.
    Kossoff EH, Silvia MT, Maret A, et al. Neonatal hypocalcemic seizures: case report and literature review. J Child Neurol. 2002;17:236–9.PubMedCrossRefGoogle Scholar
  126. 126.
    Korkmaz HA, Özkan B, Terek D, et al. Neonatal seizure as a manifestation of unrecognized maternal hyperparathyroidism. J Clin Res Pediatr Endocrinol. 2013;5:206–8. doi: 10.4274/Jcrpe.1037.PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Clarke PC, Carré IJ. Hypocalcemic, hypomagnesemic convulsions. J Pediatr. 1967;70:806–9.PubMedCrossRefGoogle Scholar
  128. 128.
    Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother. 2004;38:1002–5. doi: 10.1345/aph.1D467.PubMedCrossRefGoogle Scholar
  129. 129.
    Dickerson RN, Alexander KH, Minard G, et al. Accuracy of methods to estimate ionized and “corrected” serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr. 2004;28:133–41.PubMedCrossRefGoogle Scholar
  130. 130.
    Dickerson RN, Henry NY, Miller PL, et al. Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract. 2007;22:323–8.PubMedCrossRefGoogle Scholar
  131. 131.
    Tartaglia F, Giuliani A, Sgueglia M, et al. Randomized study on oral administration of calcitriol to prevent symptomatic hypocalcemia after total thyroidectomy. Am J Surg. 2005;190:424–9. doi: 10.1016/j.amjsurg.2005.04.017.PubMedCrossRefGoogle Scholar
  132. 132.
    Biller J, Ferro JM. In: Aminoff J, Boller F, Swaab DF, editors. Neurologic aspects of systemic disease part II: handbook of clinical neurology: Newnes; 2014. Neurologic disorders of mineral metabolism and parathyroid disease. Agrawal L, Habib Z, Emanuele NV. Neurologic disorders of mineral metabolism and parathyroid disease. Handb Clin Neurol. 2014;120:737–48. doi: 10.1016/B978-0-7020-4087-0.00049-8.Google Scholar
  133. 133.
    Kline CA, Esekogwu VI, Henderson SO, Newton KI. Non-convulsive status epilepticus in a patient with hypocalcemia. J Emerg Med. 1998;16:715–8.PubMedCrossRefGoogle Scholar
  134. 134.
    Zuckermann EC, Glaser GH. Anticonvulsive action of increased calcium concentration in cerebrospinal fluid. Arch Neurol. 1973;29:245–52.PubMedCrossRefGoogle Scholar
  135. 135.
    Hariri A, Mount DB, Rastegar A. Disorders of calcium, phosphate, and magnesium metabolism. In: Mount DB, Sayegh MH, Singh AK, Core concepts in the disorders of fluid, electrolytes and acid-base balance. New York: Springer, 2013. P. 103–146.Google Scholar
  136. 136.
    TAD C, Kauffman RP, Myles TD. Primary hyperparathyroidism, hypercalcemic crisis and subsequent seizures occurring during pregnancy: a case report. J Matern-Fetal Neonatal Med. 2002;12:349–52. doi: 10.1080/jmf.12.5.349.352.CrossRefGoogle Scholar
  137. 137.
    Hauser GJ, Gale AD, Fields AI. Immobilization hypercalcemia: unusual presentation with seizures. Pediatr Emerg Care. 1989;5:105–7.PubMedCrossRefGoogle Scholar
  138. 138.
    Nordt SP, Williams SR, Clark RF. Pharmacologic misadventure resulting in hypercalcemia from vitamin D intoxication. J Emerg Med. 2002;22:302–3.PubMedCrossRefGoogle Scholar
  139. 139.
    Dinnerstein E, McDonald BC, Cleavinger HB, et al. Mesial temporal sclerosis after status epilepticus due to milk alkali syndrome. Seizure. 2008;17:292–5. doi: 10.1016/j.seizure.2007.07.013.PubMedCrossRefGoogle Scholar
  140. 140.
    Kashouty R, Yono N, Al Samara M. Status epilepticus secondary to milk-alkali syndrome induced by hypercalcemia (oral antacids). Seizure. 2011;20:659–61. doi: 10.1016/j.seizure.2011.03.011.PubMedCrossRefGoogle Scholar
  141. 141.
    Chen T-H, Huang C-C, Chang Y-Y, et al. Vasoconstriction as the etiology of hypercalcemia-induced seizures. Epilepsia. 2004;45:551–4. doi: 10.1111/j.0013-9580.2004.57003.x.PubMedCrossRefGoogle Scholar
  142. 142.
    Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002;249:1563–6. doi: 10.1007/s00415-002-0895-x.PubMedCrossRefGoogle Scholar
  143. 143.
    Kaplan PW. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: a paradigm for eclampsia? Clin EEG Electroencephalogr. 1998;29:120–3.CrossRefGoogle Scholar
  144. 144.
    Demir BC, Ozerkan K, Ozbek SE, et al. Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome. Arch Gynecol Obstet. 2012;286:287–93. doi: 10.1007/s00404-012-2268-8.PubMedCrossRefGoogle Scholar
  145. 145.
    Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999;83:302–20.PubMedCrossRefGoogle Scholar
  146. 146.
    Soliman HM, Mercan D, Lobo SSM, et al. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med. 2003;31:1082–7. Springer, New York 2013 doi: 10.1097/01.CCM.0000060867.17556.A0.
  147. 147.
    Fairley J, Glassford NJ, Zhang L, Bellomo R. Magnesium status and magnesium therapy in critically ill patients: a systematic review. J Crit Care. 2015;30:1349. doi: 10.1016/j.jcrc.2015.07.029.PubMedCrossRefGoogle Scholar
  148. 148.
    Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3–17. doi: 10.1177/0885066604271539.PubMedCrossRefGoogle Scholar
  149. 149.
    Huijgen HJ, Soesan M, Sanders R, et al. Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol. 2000;114:688–95. doi: 10.1309/0Q7F-QTGM-6DPD-TLGY.PubMedCrossRefGoogle Scholar
  150. 150.
    Iseri LT, Allen BJ, Brodsky MA. Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium. 1989;8:299–306.PubMedGoogle Scholar
  151. 151.
    Saul RF, Selhorst JB. Downbeat nystagmus with magnesium depletion. Arch Neurol. 1981;38:650–2.PubMedCrossRefGoogle Scholar
  152. 152.
    Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012;66:411–8. doi: 10.1038/ejcn.2012.4.PubMedCrossRefGoogle Scholar
  153. 153.
    Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000;217:371–6. doi: 10.1148/radiology.217.2.r00nv44371.PubMedCrossRefGoogle Scholar
  154. 154.
    Rude RK, Gruber HE, Norton HJ, et al. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int. 2006;17:1022–32. doi: 10.1007/s00198-006-0104-3.PubMedCrossRefGoogle Scholar
  155. 155.
    Sinert R, Zehtabchi S, Desai S, et al. Serum ionized magnesium and calcium levels in adult patients with seizures. Scand J Clin Lab Invest. 2007;67:317–26. doi: 10.1080/00365510601051441.PubMedCrossRefGoogle Scholar
  156. 156.
    Sood AK, Handa R, Malhotra RC, Gupta BS. Serum, CSF, RBC and urinary levels of magnesium and calcium in idiopathic generalised tonic clonic seizures. Indian J Med Res. 1993;98:152–4.PubMedGoogle Scholar
  157. 157.
    Abdelmalik PA, Politzer N, Carlen PL. Magnesium as an effective adjunct therapy for drug resistant seizures. Can J Neurol Sci J Can Sci Neurol. 2012;39:323–7.CrossRefGoogle Scholar
  158. 158.
    Visser NA, Braun KPJ, Leijten FSS, et al. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol. 2011;258:218–22. doi: 10.1007/s00415-010-5721-2.PubMedCrossRefGoogle Scholar
  159. 159.
    Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5. doi: 10.1056/NEJM199507273330401.PubMedCrossRefGoogle Scholar
  160. 160.
    Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010:CD000127. doi: 10.1002/14651858.CD000127.pub2.
  161. 161.
    Pande SD, Wee CK, Maw NN. Unusual case of hypomagnesaemia induced seizures. BMJ Case Rep. 2009;2009:bcr0620091933. doi: 10.1136/bcr.06.2009.1933.CrossRefGoogle Scholar
  162. 162.
    Matthey F, Gelder CM, Schon FE. Isolated hypomagnesaemia presenting as focal seizures in diabetes mellitus. Br Med J (Clin Res Ed). 1986;293:1409.CrossRefGoogle Scholar
  163. 163.
    Fagan C, Phelan D. Severe convulsant hypomagnesaemia and short bowel syndrome. Anaesth Intensive Care. 2001;29:281–3.PubMedGoogle Scholar
  164. 164.
    Gandhi NY, Sharif WK, Chadha S, Shakher J. A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia. Case Rep Gastrointest Med. 2012;2012:632721. doi: 10.1155/2012/632721.PubMedPubMedCentralGoogle Scholar
  165. 165.
    Visudhiphan P, Visudtibhan A, Chiemchanya S, Khongkhatithum C. Neonatal seizures and familial hypomagnesemia with secondary hypocalcemia. Pediatr Neurol. 2005;33:202–5. doi: 10.1016/j.pediatrneurol.2005.03.009.PubMedCrossRefGoogle Scholar
  166. 166.
    Viveros H, Somjen GG. Magnesium-calcium antagonism in the contraction of arterioles. Experientia. 1968;24:457–9.PubMedCrossRefGoogle Scholar
  167. 167.
    Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke J Cereb Circ. 2009;40:1169–75. doi: 10.1161/STROKEAHA.108.527788.CrossRefGoogle Scholar
  168. 168.
    Efstratiadis G, Sarigianni M, Gougourelas I. Hypomagnesemia and cardiovascular system. Hippokratia. 2006;10:147–52.PubMedPubMedCentralGoogle Scholar
  169. 169.
    Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24:47–66.PubMedPubMedCentralGoogle Scholar
  170. 170.
    Shorvon SD, Andermann F, Guerrini R. The causes of epilepsy: common and uncommon causes in adults and children. Cambridge: Cambridge University Press; 2011.CrossRefGoogle Scholar
  171. 171.
    Reddi PAS. Disorders of magnesium: hypomagnesemia. In: Fluid electrolyte acid-base disorders. New York, NY: Springer; 2014. p. 271–83.CrossRefGoogle Scholar
  172. 172.
    Gunnerson KJ, Kellum JA. Acid-base and electrolyte analysis in critically ill patients: are we ready for the new millennium? Curr Opin Crit Care. 2003;9:468–73.PubMedCrossRefGoogle Scholar
  173. 173.
    Mallat J, Barrailler S, Lemyze M, et al. Use of sodium-chloride difference and corrected anion gap as surrogates of Stewart variables in critically ill patients. PLoS One. 2013;8:e56635. doi: 10.1371/journal.pone.0056635.PubMedPubMedCentralCrossRefGoogle Scholar
  174. 174.
    Paz Y, Zegerman A, Sorkine P, Matot I. Severe acidosis does not predict fatal outcomes in intensive care unit patients: a retrospective analysis. J Crit Care. 2014;29:210–3. doi: 10.1016/j.jcrc.2013.11.007.PubMedCrossRefGoogle Scholar
  175. 175.
    Anderson LE, Henrich WL. Alkalemia-associated morbidity and mortality in medical and surgical patients. South Med J. 1987;80:729–33.PubMedCrossRefGoogle Scholar
  176. 176.
    Fitzgibbons LJ, Snoey ER. Severe metabolic alkalosis due to baking soda ingestion: case reports of two patients with unsuspected antacid overdose. J Emerg Med. 1999;17:57–61.PubMedCrossRefGoogle Scholar
  177. 177.
    Stephani J, Wagner M, Breining T, et al. Metabolic alkalosis, acute renal failure and epileptic seizures as unusual manifestations of an upside-down stomach. Case Rep Gastroenterol. 2012;6:452–8. doi: 10.1159/000341509.PubMedPubMedCentralCrossRefGoogle Scholar
  178. 178.
    Perez GO, Oster JR, Rogers A. Acid-base disturbances in gastrointestinal disease. Dig Dis Sci. 1987;32:1033–43.PubMedCrossRefGoogle Scholar
  179. 179.
    Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatol Baltim Md. 2000;31:30–4. doi: 10.1002/hep.510310107.CrossRefGoogle Scholar
  180. 180.
    During MJ, Fried I, Leone P, et al. Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. J Neurochem. 1994;62:2356–61.PubMedCrossRefGoogle Scholar
  181. 181.
    Holmes MD, Dewaraja AS, Vanhatalo S. Does hyperventilation elicit epileptic seizures? Epilepsia. 2004;45:618–20. doi: 10.1111/j.0013-9580.2004.63803.x.PubMedCrossRefGoogle Scholar
  182. 182.
    Raybarman C. Is hyperventilation an effective activating procedure in routine clinical EEG studies in children? J Child Neurol. 2009;24:1294–5. doi: 10.1177/0883073809334383.PubMedCrossRefGoogle Scholar
  183. 183.
    Ahdab R, Riachi N. Reexamining the added value of intermittent photic stimulation and hyperventilation in routine EEG practice. Eur Neurol. 2014;71:93–8. doi: 10.1159/000353650.PubMedCrossRefGoogle Scholar
  184. 184.
    Assenza G, Mecarelli O, Tombini M, et al. Hyperventilation induces sympathetic overactivation in mesial temporal epilepsy. Epilepsy Res. 2015;110:221–7. doi: 10.1016/j.eplepsyres.2014.12.003.PubMedCrossRefGoogle Scholar
  185. 185.
    Hirabayashi Y, Okumura A, Kondo T, et al. Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness. Brain Dev. 2009;31:414–8. doi: 10.1016/j.braindev.2008.07.010.PubMedCrossRefGoogle Scholar
  186. 186.
    Schuchmann S, Hauck S, Henning S, et al. Respiratory alkalosis in children with febrile seizures. Epilepsia. 2011;52:1949–55. doi: 10.1111/j.1528-1167.2011.03259.x.PubMedCrossRefGoogle Scholar
  187. 187.
    Schuchmann S, Schmitz D, Rivera C, et al. Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat Med. 2006;12:817–23. doi: 10.1038/nm1422.PubMedPubMedCentralCrossRefGoogle Scholar
  188. 188.
    Tolner EA, Hochman DW, Hassinen P, et al. Five percent CO2 is a potent, fast-acting inhalation anticonvulsant. Epilepsia. 2011;52:104–14. doi: 10.1111/j.1528-1167.2010.02731.x.
  189. 189.
    Somjen GG, editor. Ions in the brain: normal function, seizures, and stroke. Oxford, NY: Oxford University Press; 2004. p. 432.Google Scholar
  190. 190.
    Helmy MM, Ruusuvuori E, Watkins PV, et al. Acid extrusion via blood-brain barrier causes brain alkalosis and seizures after neonatal asphyxia. Brain J Neurol. 2012;135:3311–9. doi: 10.1093/brain/aws257.CrossRefGoogle Scholar
  191. 191.
    Kaplan LJ, Frangos S. Clinical review: acid-base abnormalities in the intensive care unit–part II. Crit Care Lond Engl. 2005;9:198–203. doi: 10.1186/cc2912.CrossRefGoogle Scholar
  192. 192.
    Jung B, Rimmele T, Le Goff C, et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care Lond Engl. 2011;15:R238. doi: 10.1186/cc10487.CrossRefGoogle Scholar
  193. 193.
    Cooper ES, Lechner E, Bellet S. Relation between serum and cerebrospinal fluid electrolytes under normal and abnormal conditions. Am J Med. 1955;18(4):613–21.Google Scholar
  194. 194.
    Hunter G, Smith HV. Calcium and magnesium in human cerebrospinal fluid. Nature. 1960;186:161–2.Google Scholar
  195. 195.
    Sambrook MA. The relationship between cerebrospinal fluid and plasma electrolytes in patients with meningitis. J Neurol Sci. 1974;23(2):265–73.Google Scholar
  196. 196.
    Woodbury J, Lyons K, Carretta R, Hahn A, Sullivan JF. Cerebrospinal fluid and serum levels of magnesium, zinc, and calcium in man. Neurology. 1968;18(7):700–5.Google Scholar
  197. 197.
    Bradbury MW, Sarna GS. Homeostasis of the ionic composition of the cerebrospinal fluid. Exp Eye Res. 1977;25(Suppl):249–57.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Service de Neurologie–Centre de Référence pour le Traitement de l’Epilepsie RéfractaireUniversité Libre de Bruxelles–Hôpital ErasmeBruxellesBelgium
  2. 2.Department of Neurology, Comprehensive Epilepsy CenterYale University School of MedicineNew HavenUSA

Personalised recommendations